The Court's decision hands a big victory to private fund managers while rifts in the LP community may have aided the downfall of the regulatory package.
The firm has set a €400m hard-cap for ArchiMed MED Rise, according to documents prepared by a US pension.
The firm plans to launch its Core Private Equity product this year and will invest via secondaries, according to CIO and CEO Benoît Durteste.
Some 38% of GPs offered early bird discounts on management fees in 2023, a marked increase from 18% the prior year, according to research from the law firm.
The $1.6bn BPEA EQT Mid-Market Growth Fund is nearly 18% deployed across four deals, two of which came from India, partner Nicholas Macksey tells PEI.
The GP stakes giant is seeking $13bn for its sixth flagship, according to PEI data.
The Mumbai-based manager, which closed a $700m continuation fund in April, will begin fundraising for its 10th flagship this year, PEI understands.
Asia Fund VIII, which closed below target, is TPG’s largest Asia-focused fund, according to the firm's latest earnings call.
Up to 80% of capital raised for the vehicle will target direct investments, with the remainder targeting primaries and secondaries investments, PEI understands.
Blue Owl also held a first close of about $600m for a new mid-cap GP stakes fund, $500m of which was seed capital provided by partner Lunate, sources told affiliate title Buyouts.